For Researchers
A working reference for NUS faculty, PhDs, postdocs, and research staff exploring how their work becomes patents, licensed technology, ventures, or industry collaborations. Tech Transfer is not a barrier — it's the office that handles the paperwork so you can keep doing the work.
What brings you here?
Pick the question that matches what you actually need right now. Each card jumps you to the relevant block on this page or routes you out.
I think I have an invention. What do I do?
Disclosure pathway →
02How do patents and IP ownership actually work at NUS?
About patents & IP →
03I need an MTA or NDA for an external collaborator.
Agreements →
04I need funding to develop my research toward a product.
Funding programmes ↗
05I want to spin out a company based on my research.
From research to venture →
06I just want to talk to someone in TTI.
Find your TTO →
Disclosure pathway
A visual map of what TTI does after you submit a disclosure form. Realistic timelines, named ownership at each step, and what's expected from you (the researcher) versus what TTI handles. Submit a disclosure →
| Step | What happens | Typical time | Owner |
|---|---|---|---|
| 01 | Submit disclosure form You describe the invention, who contributed, prior art you're aware of, and any external commitments. | — | Inventor / PI |
| 02 | Initial review & intake TTO assigned to your domain reviews for completeness, IP clarity, NUS pre-existing obligations. | — | Domain TTO |
| 03 | Patentability & commercial assessment External patent counsel runs prior-art search; TTO assesses commercial potential. Outcome shared with you. | — | TTI + counsel External patent attorney |
| 04 | Filing decision NUS decides whether to file, in which jurisdictions. You're consulted; if NUS chooses not to file, IP rights may be released. | — | Filing committee |
| 05 | Provisional patent filing External counsel drafts and files the provisional. You review claims. NUS pays filing costs. | 6–12 weeks | TTI + counsel External patent attorney |
| 06 | Marketing & licensing TTI lists the technology in licensable catalogue, runs outreach to matching companies, negotiates licensing/sponsored research agreements. | — | Licensing officer |
| 07 | Revenue & royalty distribution Revenue shared per NUS IP policy: typically 50% to inventors, 50% to NUS/faculty/department, per current policy. | Per agreement | NUS Finance + TTI IP revenue desk |
[CONFIRM step ownership and timelines with TTO team — figures and stages are illustrative]
About patents & IP
The reference material researchers actually need — pulled out of the accordion and into something readable. Pick a topic on the left.
An invention is a new and useful process, machine, manufacture, or composition of matter — or a new and useful improvement of any of these. At NUS, software, methods, biological materials, and engineered designs all qualify if they meet the legal tests of novelty, non-obviousness, and utility.
The shortest practical heuristic: if you're about to publish or present something that you also think a company might want to commercially license, that's a strong signal you should file a disclosure first.
Invention is a legal threshold, not a quality judgment. A disclosure is just a record. TTI decides whether to file.
Quick rule of thumb
If you're going to publish, present at a conference, post a preprint, or share a draft externally — get a disclosure in before. Public disclosure can affect patentability in many jurisdictions, especially Europe.
By default, NUS holds title to inventions made by faculty, staff, and students using NUS resources. This is governed by the NUS IP policy.
Revenue sharing splits between inventors, the department, and the university are defined in current policy. TTI publishes the formula and can walk you through your specific situation.
[Full content to be confirmed with TTI team]
Different IP types protect different things. Patents protect inventions (processes, machines, compositions). Copyright protects creative expression (code, papers, designs). Trade secrets protect confidential information that derives value from its secrecy.
At NUS, the relevant type depends on what you've created. TTI can help you determine the right protection strategy.
[Full content to be confirmed with TTI team]
A provisional patent application establishes a priority date and gives you 12 months to develop the invention and file a full (non-provisional) application. It is not examined and does not issue as a patent.
A full (non-provisional) patent application is examined by the patent office and, if granted, gives you enforceable rights.
[Full content to be confirmed with TTI team]
The Patent Cooperation Treaty (PCT) allows a single international application to be filed, designating multiple countries. NUS evaluates commercial potential across jurisdictions before committing to international filing costs.
[Full content to be confirmed with TTI team]
Publication before filing can affect patentability. In some jurisdictions (particularly Europe), any public disclosure before filing destroys novelty. The US has a 12-month grace period, but this is not universal.
The safest approach: file a disclosure with TTI before submitting a paper, posting a preprint, or presenting at a conference.
[Full content to be confirmed with TTI team]
When NUS researchers collaborate with researchers at other institutions, IP ownership depends on the collaboration agreement and who contributed to the inventive concept.
TTI negotiates joint ownership agreements with partner institutions. Contact your domain TTO before publishing or disclosing jointly-developed inventions.
[Full content to be confirmed with TTI team]
Research funded by government grants or industry sponsors may carry IP obligations that modify default NUS policy. Many NRF and A*STAR programmes have specific IP provisions. Industry-sponsored research typically gives sponsors first-refusal or licensing options.
TTI tracks all sponsor commitments per project. Disclose your funding sources when filing a disclosure form.
[Full content to be confirmed with TTI team]
Agreements
Both have standard NUS templates. Both can be initiated through TTI. Below: when to use which, who signs, and how long it typically takes. For anything beyond these two, email your domain TTO directly.
Material Transfer Agreement
For sending or receiving research materials
Use an MTA when you're shipping or receiving physical research materials — biological samples, compounds, cell lines, tissue, or proprietary materials — to or from another institution or company.
Non-Disclosure Agreement
For confidential conversations with external parties
Use an NDA before sharing unpublished research, technical details, or pre-disclosure invention specifics with an external party.
Need something else — a sponsored research agreement, a licensing deal, a consulting contract? Email your domain TTO directly.
From research to venture
Some NUS technologies become licenses to existing companies. Others become spinouts — new ventures founded on the underlying IP. If you're considering the spinout path, two routes fit most situations.
A graduate degree designed around building a company on top of your research. One year, structured cohort, hands-on venture work alongside business fundamentals. Suits researchers who want a guided path with peers.
If you have IP, a co-founder, and a clear commercial thesis, TTI structures a spinout licensing deal directly. NUS retains an equity stake; you and your co-founders run the company. Connects to BLOCK71 infrastructure and translational funding.
Industry collaboration
Research that's funded by, scoped with, or done alongside an industry partner. Three formats fit most arrangements — TTI handles the contracting in each.
Industry funds a defined research project in your lab. NUS retains IP with the sponsor receiving a first-look or licensing option.
See terms →Both parties contribute IP, talent, and resources. IP outcomes are jointly owned per a project-specific agreement.
See terms →Industry-paid PhDs, postdocs, or research engineers placed within your group on co-supervised projects.
See terms →Looking from the industry side instead? See For Industry → →
Researcher stories
Three researchers who took an invention through Tech Transfer to license, spinout, or industry deployment.
Spinout · NUS Engineering
Aravind's diagnostics IP became the foundation of his spinout, structured through TTI. Eleven months from disclosure to seed.
Read story →Licensing · NUS Medicine
Faculty spinout from NUS Medicine. The technology is now serving three continents.
Read story →Sponsored research · NUS Materials
How a routine MTA led to a five-year sponsored research relationship and three patent filings.
Read story →Common questions about IP
The questions researchers ask most often about NUS IP policy, ownership rules, and revenue sharing. If yours isn't here, your TTO can answer directly.
Who owns the IP I create as an NUS employee or student?
By default, NUS holds title to inventions made by faculty, staff, and students using NUS resources. Specific allocation is governed by the NUS IP policy, with revenue-sharing splits between inventors, the department, and the university.
What if my research was funded by a government grant or industry sponsor?
Funder terms can override default NUS policy. Many government grants (e.g. NRF, A*STAR programmes) have specific IP provisions. Industry-sponsored research typically carries first-refusal or licensing options. TTI tracks all sponsor commitments per project.
Can I retain ownership of my invention?
In some cases, yes. If NUS chooses not to file or pursue commercialisation, IP rights may be released back to the inventor on request. The release process is handled through TTI.
How is licensing revenue shared?
Per current NUS policy, revenue is typically split among inventors, the department, the faculty, and the central university. Specific percentages depend on the agreement type and current policy version. TTI publishes the formula.
What happens if I leave NUS while my IP is being licensed?
IP ownership stays with NUS. Inventor revenue shares typically continue to be paid to the named inventors regardless of whether they remain at NUS, per the policy in force at the time of disclosure.
Can I use my own invention after I leave NUS?
Depends on what was licensed and to whom. If exclusively licensed to a third party, your use may be restricted. If not licensed, NUS often grants former inventors the right to continue using the IP non-commercially. Check with TTI before assuming either way.
Reach out directly. We'll route your inquiry to the right person — disclosure, agreements, licensing, or funding — based on your research domain.
[Contact name / TTI office]
Technology Transfer Office